Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01770860 · ClinicalTrials.gov registry record · NA

A Test of Different Kinds of Bandages on Healing of Wounds

A NA study, sponsored by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies.

Completed
Registry status
NA
Development phase
46
Enrollment target

NCT01770860: Completed NA study, sponsored by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies.

NCT01770860 is a NA study that has completed, run by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01770860, a NA study, has completed, sponsored by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target

Study Summary

This two-week study will compare the healing of minor wounds when no bandage is applied against four different types of bandages. The study investigators will make five small wounds similar to scrapes (about a half-inch square) on the back of subjects who qualify to participate in the trial and have given informed consent. Four of the wounds will be covered by different bandages and one will be left uncovered. Participants will visit the clinic every day for 2 weeks or until all the wounds are healed (whichever comes first). At the clinic, the bandages will be removed, the doctor will score the wounds, a picture will be taken of the wounds and new bandages will be applied. It is expected that some pain and itching will be experienced, because they are part of the normal wound healing process. Subjects will be asked about adverse events at each visit and will have the opportunity to discuss issues or concerns with the investigator or the doctor during the course of the trial. It is expected that the wounds will be completely healed within 14 days, but if not, the participant will need to return to the clinic for follow-up treatment until the wounds are completely healed. We will see if the different bandages help with the healing of the wounds during the study.

Primary Outcome

Wound epithelialization will be recorded daily for each wound (until healed) by the doctor on a scale of 0-5, where 0= No presence of epithelialization (no sign of healing), a bandage is necessary and 5=Wound is 100% epithelialized (healed), no bandage necessary. The median time to healing will be estimated from the survival curves using the Kaplan-Meier method for each test product. Time to healing is defined as the time from wounding to 12:00 pm of the day the wound is 100% epithelialized (rec

Interventions

  • DEVICE 6660
  • DEVICE 4314
  • DEVICE 8336
  • DEVICE 4840

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2013-01
Est. Completion 2013-02
Phase NA

What the finished NCT01770860 record still lists

NCT01770860 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 4 interventions - of which 6660 is the first listed.

NCT01770860 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01770860 about?

NCT01770860 is a clinical study titled "A Test of Different Kinds of Bandages on Healing of Wounds". This two-week study will compare the healing of minor wounds when no bandage is applied against four different types of bandages. The study investigators will make five small wounds similar to scrapes (about a half-inch square) on the back of subjects who qualify to participate in the trial and hav...

What is the current status of trial NCT01770860?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2013-01. Estimated completion is 2013-02.

What interventions are being tested in trial NCT01770860?

The interventions under investigation include: 6660 (DEVICE), 4314 (DEVICE), 8336 (DEVICE), 4840 (DEVICE).

Who is sponsoring clinical trial NCT01770860?

This trial is sponsored by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01770860's enrollment target sits among peer trials

46 1402nd of 2000 higher than 590 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01770860, the US trial registry maintained by the National Library of Medicine. NCT01770860 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.